Fabio De Vincenzo

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

Paolo Andrea Zucali, Tommaso De Pas, Giovannella Palmieri et al. · Journal of Clinical Oncology · 2017 · 169 citations

Cancer Management, Thymic Carcinoma Previously, Immunology +20

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

Giovanni Luca Ceresoli, Paolo Andrea Zucali, Fabio De Vincenzo et al. · Lung Cancer · 2011 · 139 citations

Pemetrexed-based Chemotherapy, Surgical Oncology, Medicine +7

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

Giovanni Luca Ceresoli, B. Castagneto, Paolo Andrea Zucali et al. · British Journal of Cancer · 2008 · 118 citations · Full text

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro et al. · Journal of Clinical Oncology · 2010 · 109 citations · Full text

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Giovanni Luca Ceresoli, Paolo Andrea Zucali, Manlio Mencoboni et al. · British Journal of Cancer · 2013 · 105 citations · Full text